Items

• 
  2022-06-17

  The FDA authorizes COVID-19 shots for infants and preschoolers

  This is a news story from NPR by The Associated Press. The United States has authorized the use of vaccines for infants and preschoolers. The Center for Disease Control and Prevention (CDC) is debating how the vaccines are to be administered. The article says that studies support giving these age groups the vaccines, as they are said to be effective and have minor side-effects.
• 
  2022-06-08

  Moderna says updated Covid-19 vaccine booster shows stronger antibody response against Omicron

  This is a news story from CNN by Jamie Gumbrecht. Moderna believes that their COVID-19 booster is effective against Ominicron, and more effective compared to the normal two doses. The claim is that the booster provided a stronger antibody response than the initial two doses.
• 
  2022-05-05

  FDA restricts J&J’s Covid vaccine due to blood clot risk

  This is a news story from NBC News by The Associated Press. Due to new findings, the J&J vaccine has been restricted by the FDA due to blood clot risks. It is not to be given to anyone unless they can't receive a different vaccine. Americans are now recommended to only be using Pfizer or Moderna shots instead.
• 
  2022-04-15

  Moderna is Developing Two New Vaccines-- And One Could Protect Against the Common Cold

  This is a news story by health.com written by Alyssa Hui. This story is about Moderna expanding its biotechnology into creating new vaccines using similar techniques the COVID vaccines have used. One of these vaccines will be used to help combat RSV, which is a virus that hospitalizes an average of 177,000 adults per year, according to the CDC. Another illness that Moderna is looking to use vaccines against are four other endemic human coronaviruses. Moderna does not claim they offer 100% guaranteed protection, but that they can benefit people greatly for reducing chances of contracting certain illnesses. Moderna wants to ensure that the vaccines are safe and will go through testing procedures to do so. They are hoping that there will be more uses for mRNA style vaccines in the future, and not just for the coronavirus.
• 
  2022-04-14

  COVID-19 Vaccines May Protect Your Baby

  This is an Instagram post by asianyouthcenterorg. This post is giving information on vaccinations and pregnancy. It says that Pfizer and Moderna are the most recommended vaccines for expecting mothers.
• 
  2022-04-04

  Vaccination Celebration

  This is an Instagram post by ucr_chc. This is of a celebration where kids are encouraged to go and get vaccinated. The celebration flyer says that there will be food and kids toys available. The event is also giving away free testing kits, and will do booster shots as well. This event was held in Jurupa Valley, California.
• 
  2022-01-19

  Man Calls Out PM Orbán after Mother Dies from Coronavirus

  This is a news story from Hungary Today by Júlia Tar. A man's mother and sister from Nagykanizsa both died from the Coronavirus. Later, this man calls out Prime Minister Viktor Orbán because he believes PM Orbán did not properly protect his family. His mother was vaccinated with Sinopharm, a Chinese vaccine. The PM himself received Sinopharm as his first two doses, with Moderna as his third dose. The man describes feeling hurt seeing his mother die in the hospital after she contracted the Coronavirus.
• 
  2021-10-07

  Covid Vaccine Reminiscence

  This is a recording I did of myself where I reminisce on my Covid Vaccine experience and the feelings it brought
• 
  2021-03-18

  Oakland clinic offers Mayan interpreter for COVID-19 vaccinations

  Oakland clinic offers Mayan interpreter for COVID-19 vaccinations La Clinica de La Raza is targeting Latin Mam or Mayan-speaking community with translation service Thursdays OAKLAND — A new COVID-19 vaccination clinic in the Fruitvale neighborhood is offering interpreter services for the Latin Mam or Mayan-speaking community. This month, La Clinica de La Raza began offering the community-targeted vaccination service at 32 locations across the Bay Area, including ASCEND Elementary School on East 12th Street, where Latinos who speak Mam, K’iche ‘and Q’eqchi’ can get translation help from appointment to inoculation on Thursdays. There are over 22 different Mam dialects spoken primarily by people of Guatemalan and Mexican descent. According to a recent UC San Francisco study, Mayan people with Guatemalan roots are the fastest-growing ethnic group in Oakland. “I’m here to support my community, getting them the service that they deserve,” Brenda Sucely Perez, the on-site interpreter at ASCEND, said last week while about 450 eligible people were vaccinated. Staff at the Fruitvale site have administered roughly 2,000 Moderna vaccines per week since opening on March 4, according to La Clinica officials. Salvador Garcia, an Oakland firefighter, volunteered at the vaccination clinic. “Coming to get the vaccination is a good thing because it would help prevent the spread,” Garcia said, adding that it’s especially important given how close relatives in the Latino community live. “When you’re around people in such tight quarters around here, the way the families live with each other, it’s just good to have the preventative measure of the vaccination.” It’s also one of the reasons the nation’s first and strictest stay-at-home orders proved ill-suited for the hard-hit Latino community, a four-month Bay Area News Group investigation found. That analysis showed case rates for the region’s Latino residents are nearly four times higher than White residents, while the Latino population has fared worse against the virus across California. During the fall case surge, economic pressure to keep working outside the home became another major factor in the Latino community’s higher COVID-19 positivity rate in the Fruitvale neighborhood than the rest of the state, according to a UCSF study conducted in September. The results of that study found that antibody-positive prevalence was 9.8% overall among people who live and work in Fruitvale, a predominantly Latino neighborhood. The number spiked to 26.8% among the Latin Mam, or Mayan, speaking community, USCF [sic] researchers noted. The COVID-antibody test shows that someone once had coronavirus.
• 
  2021-06-28

  My Pandemic Experience

  When the pandemic was coming, I was initially relieved. I was supposed to fly to Chicago to visit my sister and go to our favorite band’s (Keane) concert, but as a person with anxiety and panic disorder who is terrified of airplanes and crowds it allowed me to back out. The concert was cancelled. It was the excuse I needed to back out without shame or blame. It seems silly now, but at the time covid seemed more like a bad cold or flu to me. It seemed like another Swine Flu or Avian Flu or other scare in recent memory which hadn’t amounted to a plague style pandemic. Lockdown was even kind of nice at first. My husband, daughter, and I got to spend a lot of family time together. I had taught ESL online for a number of years previously, so converting my in school classes to online was easy. I had no problems teaching over Zoom. I’m a homebody anyway, by habit and by anxiety, so this was great… until the body count started. I was horrified and sickened to hear about the freezer containers being used in New York City to store the overflow of bodies. The germaphobia that had plagued me in childhood, that I had gone to years of therapy to overcome, came roaring back with a vengeance. Like everyone else, I went to the grocery store to stock up so I wouldn’t have to leave me house for awhile, only to find shelf after shelf empty. As a super health conscious, organic, vegan my choices were extremely limited. My husband and daughter aren’t vegan, but they do eat only organic, which became impossible. Soap, disinfectant, cleaners, and hand sanitizers were nowhere to be found. At a time when it was so important to be as clean and healthy as possible all those modern conveniences were utterly gone. I felt helpless. I imagined that people living during pandemics like the bubonic plague and Spanish flu must have felt similarly. After a couple of weeks, quarantine started to feel more like a claustrophobic prison sentence than a family vacation. I missed my sister, my parents, my friends, my colleagues, and my students. On my birthday and Easter I just had to wave at my parents through the glass door. My favorite hobby- taekwondo, which I had started in order to relieve stress and help with my anxiety was taken from me. I had to do the classes online from my living room, which was nearly impossible. I felt trapped. A raging epidemic across the planet from which there was no escape. If I spent too much time thinking about it, I would start to feel the claw of panic. By the time summer arrived I was at breaking point. Luckily with summer we had some reprieve. Case loads declined, and I started meeting my best friend outside. We socially distanced ourselves and wore masks, but we were together and that was a start. By the end of summer she and her boyfriend were on our “quaranteam” that is we decided we could see each other since we weren’t seeing anyone else. In the fall school started. Since I teach at a Catholic school we were able to have school in person full time, though we had students in every grade who opted to go remote. But my bestie and I were back in the building with most of the kids, and I started to feel less trapped. I was going to stores masked and my daughter was also in school. But as soon as Thanksgiving hit everything changed again. So many people ignored all of the recommendations and restrictions and got together with family and friends. It made me so angry that people were so careless. A friend of mine had a large family in Pennsylvania who all got together for Thanksgiving. She didn’t go because she thought it was reckless. 8 out of 14 people at the family dinner got covid and 2 of them died. Then at Christmas, my great uncle passed. No funeral. No wake. Nothing. Schools shut down again. We were trapped. Then the vaccines came. It was nearly impossible to get one for a long time even if you were eligible. Slots filled as fast as they were posted. You needed to present a lot of proof of eligibility in order to get one. As a teacher, I was able to get mine earlier than many others. I got the Moderna. The first shot made me feel a little sick for a few hours, but with the second I had a fever of 103.5, aches, chills, nausea for 12 hours and a general malaise for 3 days. A friend of mine in taekwondo, who has some autoimmune problems, had a severe reaction after her first Moderna vaccine. She has had side effects for a few months now that are not going away. She has dizzy spells and heart palpitations regularly. She is undergoing testing and being monitored by the CDC. Despite some horror stories, the vaccine is still the absolute best thing that we could have hoped for. I would like my daughter to get it as soon as they open it to the under 12 population. A lot of people won’t get the vaccine because they are in the “Science is fake, I’m a Trump supporter” camp. In my opinion, Trump’s misinformation and mishandling of the pandemic cost tens of thousands of American lives, and his diversive legacy is going to cost us dearly for many years to come. It is now June again. School just finished. New York State is allowing people to enter buildings unmasked if they are vaccinated, but few people are actually requiring any proof. Given that the people with a cavalier attitude toward wearing masks are many of the same people who are against getting vaccinated, an honors system policy towards wearing masks is really just a no-mask policy. It is very frustrating to me that people can’t just deal with masks for a while longer to fully insure this disease’s eradication before we have another relapse and find ourselves back in quarantine again.
• 
  2021-06-03

  My Covid Vaccine Experience

  These are the two Facebook posts I made the day I got my first shot and my second. I received the Moderna vaccine. As a teacher, I was able to get mine sooner than many others. Many people I know had (and still have) reservations about getting the vaccine. I believe in science. I believe in vaccines. It is disheartening and dangerous to see so many Americans throwing away an opportunity to protect themselves, their families, and their community because of politics. Science should not be political. The vaccine did make me feel ill, especially the second one, but it was temporary. I would do it a hundred more times if I had to. A friend of the family said they would not get the vaccine because, "What's in it for me? Even if I get Covid, I am young and healthy, unlikely to die." I found that statement alarmingly self-centered. Getting the vaccine isn't about you as individual as much as it is about you protecting your community and the world. As the saying goes nowadays, "Until all of us are safe, none of us is safe."
• 
  2021-03-12

  Life in a Needle

  Throughout medical history vaccinations have been imperative in order to fight diseases and viruses. As a child these vaccinations start at two months and tend to continue through our lives. Most vaccines are mandatory but there are some that are voluntary which leaves us contemplating our decision. The contemplation on getting a vaccine is why I chose a picture of my COVID-19 Vaccination Record Card to be submitted as my primary source. When COVID first hit the United States, we weren’t really prepared for the devastation that it brought right along with it. When I first heard about COVID it still hadn’t reached the United States and that was around January but then around March New York started going into lockdown. The lockdown period was pretty difficult to deal with as the way of life completely changed. Mentally, emotionally and physically it took a toll on me. As a person that was barely at home because of school and work the lock down caused great anxiety. From the moment the world heard about the first case it went into creating a vaccine that could prevent the number of cases of deaths and hospitalizations from increasing. As pharmaceutical companies started the research to create a vaccine, I was pretty skeptical about it. I was refusing to get the vaccine if they succeeded in creating it because there was just so much doubt going through my head. I was unsure what the vaccine contained and if it would work in the prevention of catching COVID. But long behold a vaccine was created but of course there were so many side effects that came with the shot. With everything that was going wrong with the vaccine during the experimentation period it just strengthened my decision to decline the shot. My views started to change once I started to hear that many people weren’t getting any symptoms from the Moderna and Pfizer vaccines. These vaccines required the person to receive two doses in order to be “immune” to COVID. Another reason that caused me to change my views on receiving the shot was the fact that I wanted to travel, and the government was requiring a vaccination passport in order to do so. The first dose of vaccines was only available to the elderly and to the healthcare workers who were risking their lives coming into contact with COVID patients. Then they started extending the qualifications needed for someone to receive the shot which included: preexisting conditions, obesity, high risk conditions, and many other qualifications. These are just of the few qualifications that was asked for in order for someone to be eligible to receive a vaccination. Because I have a preexisting condition, I was eligible to receive the COVID 19 vaccine. It was pretty difficult trying to get an appointment due to the high volume of people who wanted to receive the shot. After multiple attempts in trying to secure my appointment, I succeed with Walmart. I received my first Moderna vaccination on March 12, 2021 and my second vaccination on April 23, 2021. I was content on receiving the Moderna vaccine because it wasn’t recalled for causing health problems like the rest of the vaccinations from other pharmaceutical companies were causing. After a few hours of receiving my first shot I started to feel dizzy and very lightheaded to the point that I couldn’t drive at work. With the second shot my symptoms were: dizziness, fever, body aches, chills, change of smell and taste and nausea. The second shot was stronger than the first one but I’m glad that those were the only symptoms I experienced. But the one thing that both shots had in common after receiving them was the soreness of the arm for multiple days. Now that is has been almost a month that I received my second shot almost all the symptoms have vanished except for my change of smell and taste. Because the shot as altered my sense of smell and taste it has made it unbearable for me to smell or eat meat but I’m hoping that it will subside soon. The decision on receiving the COVID 19 vaccine is a daunting one to make as there can be many factors that can influence you. I received the vaccine as a precaution to myself and others. I also took it in order to travel and not worry about being prevented from boarding a flight because I can’t provide proof of the vaccination record card. I think this new vaccine is going to be a lot like the Flu shot as it comes in seasons and its up to the person to decide whether or not they’re going to get it. I’m just happy that the government hasn’t made it mandatory because there is still a lot of people who are pretty skeptical about it. The decision of our life is in a needle.
• 
  2021-04-09

  Clinical Trials for HIV Vaccine has been Overwhelming Success due to the help of COVID-19 Vaccine

  Clinical trials for HIV vaccines have been overwhelmingly successful with a 97% success rate at stimulating the production of rare immune cells which could lead to vaccines in the future. The COVID-19 vaccine has led to the increased development of m-RNA dosed vaccine which is also found in many other vaccines. By producing the COVID-19 vaccine has led to much more funding and research into the mRNA vaccine field which will bring about new changes in medicine in the future.
• 
  2021-04-16

  Vaccine Booster Shots

  This article is about the Moderna and Pfizer vaccine shots will likely require follow-up booster shots. The executives of both companies announced that it is likely that people that received the vaccine will need their first booster shot within 12 months of receiving the vaccine, then possibly yearly shots afterward. At the end of the article it does note that the Pfizer vaccine is still 93.1% effective 6 months after the vaccine and Moderna reports 90% effective after the 6 month period. However it still seems that we will have to receive booster shots, which is no big deal unless people have the side effects that they had from the original vaccine. This would absolutely prevent many people from following through or even receiving the original vaccine.
• 
  2020-04-13

  Forgot my vaccine card to my second appointment

  I forgot my vaccine card to my second Moderna dose appointment at ASU. It's silly of me to forget about something so major. They asked if I had a photo of it and I thought they wanted it to prove I had received one. I did have a photo but I had covered the information on it for a picture for my story on instagram. They just waived me along and gave me my second dose anyway, they came to me about 5 minutes after my shot with a new vaccine card. Now I have two different vaccine cards, maybe one will be my future "travel id".
• 
  2021-04-01

  News Article: ASU watching new COVID-19 'Arizona variant' with a mutation known to weaken vaccines

  By Amanda Morris of the Arizona Republic: Arizona State University researchers have found a home-grown variant of the coronavirus emerging in Arizona that they say should be monitored closely because it carries a mutation known for weakening vaccines. In a non-peer reviewed study that published Sunday, researchers said they have detected 17 cases of the new variant since February, 15 of which were in Arizona. The other two cases were found in Houston in late February and New Mexico in early March, suggesting that the variant has begun to spread. "My hope is that we do not see more of these cases. The whole point of surveillance is to keep this from spreading," said Dr. Efrem Lim, an ASU virologist and assistant professor. The variant is known as the B.1.243.1 variant, and descends from a common lineage of the virus called B.1.243, which nationally makes up about 2.5% of all cases, according to David Engelthaler, director of the Translational Genomics Research Institute's infectious disease division in Flagstaff. "It's not dominant. But, there's a fair amount of that lineage that has been able to hang around," Engelthaler said. "It seems to have picked up this E484K mutation, what we call the 'eek!'" This E484K mutation has also been seen in the variants first detected in South Africa and Brazil, as well as one new variant recently discovered in New York. Numerous studies have shown that this mutation — located in the spike of the virus — lowers antibody responses to the virus and could weaken vaccines. Antibodies are one of the body's tool to recognize and fight the virus. The E484K mutation has been shown to weaken antibody responses. One study from Seattle showed that it caused the neutralizing effects of antibodies to decrease by tenfold, and numerous other studies have shown similar results. American vaccine development company Novavax reported that its COVID-19 vaccine was 96.4% effective against the original coronavirus strain and 86.3% effective against the U.K. variant, but was far less effective in South Africa, where the South Africa variant carrying this mutation is dominant. In the South Africa trials, the vaccine was shown to be 48.6% effective overall, and 55.4% effective in HIV-negative individuals. Moderna announced a sixfold reduction in antibody responses from its vaccine against the South Africa variant, and Pfizer observed a drop in vaccine-induced antibody responses against the South Africa variant. The Johnson & Johnson vaccine is reported to be 64% effective against moderate to severe COVID-19 in trials in South Africa vs. 72% effective in U.S. trials. Though the E484K mutation appears to reduce antibody response and possibly reduce vaccine efficacy, Lim stressed that vaccines still work well and said people should get their vaccines as planned. Scientists are monitoring mutations in the spike of the novel coronavirus. Community spread is a concern Though the new Arizona variant carries this mutation, it's still possible for the variant to fizzle out and stop spreading. Lim said researchers have found two other cases where viruses within the B.1.243 lineage independently picked up the E484K mutation, but did not spread. "In both cases, they never led to more transmissions," Lim said. Engelthaler has also tracked other lineages where the E484K mutation showed up, but those strains fizzled out. Overall, researchers have detected over 60 samples containing the E484K mutation statewide, according to TGen's Arizona COVID-19 sequencing dashboard. In order to continue spread, Engelthaler said variants need to be very "fit." "This mutation has popped up on multiple instances and then just goes away," he said. "This one mutation by itself doesn't give the virus superpowers." "It’s definitely a mutation of concern but time will tell if it will be a variant of concern," he added. If the mutation shows up in a more fit version of the virus, then Engelthaler said it becomes more of a concern. The new variant in Arizona is different than past cases because it has already spread from one person to another and could spread further, according to Lim. He said "one-off" mutations here and there are normal, but that the bigger question is about the transmission levels of this variant. A variant's ability to spread to others is also dependent on human behavior, Lim said. If people follow public health guidelines, they are less likely to spread variants to others. In total, Lim said the new Arizona variant has 11 mutations, which is "quite a bit more" than normal virus variations. These 11 mutations could be helping the virus survive or spread and could also act as a "fingerprint" to help researchers identify the new variant, Lim said. Another one of the 11 mutations is located in the spike that the virus uses to attach to and infect cells. Engelthaler said that because of the importance of the spike, any mutations in that area could affect things like how fast the virus spreads or how severe the related illness is. Both Lim and Engelthaler said it's too soon to tell whether the other mutations in this variant have any effect. Overall, this variant still seems to account for a very low percentage of overall cases in the state, according to Dr. Joshua LaBaer, the executive director of ASU's Biodesign Institute. ASU researchers wrote that it's still possible there are more undetected cases of the variant since there are limited efforts to genetically monitor the virus nationwide. In Arizona, roughly 1.3% of cases overall have been genetically sequenced, or analyzed, according to TGen's Arizona COVID-19 sequencing dashboard. In February and March, over 3% of cases were sequenced, higher than national rates of sequencing, which were below 1% in January. ASU is working with the Arizona Department of Health Services to monitor the new variant and hopefully prevent further spread through contact tracing and other public health measures, Lim said. California and UK variant cases rise Currently the Arizona variant is only considered a "variant of interest" and not a "variant of concern." These are different categories outlined by the CDC and used to assess the risk level of each variant. The CDC defines "variants of interest" as those that are associated with potential changes, whereas "variants of concern" have evidence showing actual changes such as increased transmission, more severe disease or antibody evasion. There are five variants of concern, which include variants first identified in the United Kingdom, South Africa, Brazil and California. Two variants from California were elevated from variant of interest to variant of concern this month and have rapidly spread in Arizona. "They're closely related to each other and have definitely been documented with increased transmissibility and some impact on some antibody treatment," Engelthaler said. In November 2020, both the California variants accounted for only 0.73% of Arizona's genetically sequenced samples. By March, they accounted for 31.64% of samples and are predominant variants statewide. One non-peer reviewed study from the University of California San Francisco showed weaker antibody responses against the California variants. Because of concerns that monoclonal antibody treatments may be less effective against these two variants, the U.S. Department of Health and Human Services announced two weeks ago that it would limit the distribution of one treatment to states with high levels of the California variant, including Arizona. The California Department of Public Health also recommended that the state stop distributing the treatment, which is made by American pharmaceutical company Eli & Lily. In a health alert, the department said this treatment was unlikely to be active against the California variants. The U.K. variant, which is highly contagious, has also been spreading statewide ever since it was first detected in late January. In March the U.K. variant accounted for 4.72% of genetically analyzed samples. Currently, Engelthaler said Arizona has over 100 cases of the U.K. variant and over 1,000 cases of the California variants. Arizona also detected its first cases of the South Africa variant last week. So far, Lim said that all of the variants of concern are manageable and have not risen to the level of "variant of high consequence," which the CDC defines as variants that are shown to significantly reduce the effectiveness of prevention and medical measures. "The risk is whether one of these current variants of concern acquire additional mutations that push it up to the next level," Lim said. To prevent further mutations, LaBaer said it's important to prevent spread of the virus by continuing to follow health guidelines and getting vaccinated. The more the community can prevent the spread of the virus, the less mutations will occur, he said. "We're kind of in this race right now between the developed dominance of these much more infectious variants that are now spreading throughout the country and getting people vaccinated," LaBaer said. "At the moment, I'm a little worried that the spread of this virus is so fast that that may outpace our ability to get vaccines in arms." He said it was theoretically possible that new variants could escape the vaccines, meaning that the public would move backward away from reaching herd immunity. But Lim said the vaccines can easily be updated to protect against new variants. Pharmaceutical companies like Pfizer and Moderna are already working on developing updated booster shots. In the meantime, researchers will continue to monitor the Arizona variant to see if it spreads further. Engelthaler said he expects the most fit variants of the virus to become more dominant statewide as people continue to get vaccinated and stamp out less successful strains. "There's a bit of a race here with the virus — a survival of the fittest race," Engelthaler said. "But what we don't want is to raise too much concern that things are going in the wrong direction...what we're doing is closely watching the evolution of a virus like we never have before. It's good that we have this capability, it's more important to put it into context." Amanda Morris covers all things bioscience, which includes health care, technology, new research and the environment. Send her tips, story ideas, or dog memes at amorris@gannett.com and follow her on Twitter @amandamomorris for the latest bioscience updates. Independent coverage of bioscience in Arizona is supported by a grant from the Flinn Foundation.
• 
  2021-03-19

  Post-vaccine handouts

  After receiving the first dose of the Moderna vaccine, the volunteers at ASU handed out these booklets with information about the Moderna vaccines. It lets you know that no vaccine is FDA approved and that you should report any symptoms to the CDC using the vaccine safe program with your smartphone.
• 
  2021-03-16

  Graham County (AZ) to open up COVID-19 vaccine to all residents 18 years and older

  Staff Reports SAFFORD – The Graham County Department of Health and Human Services has announced that starting Monday, March 22, any resident of Graham County who is 18 years old or older will be eligible to receive a vaccine for COVID-19. Those who would like a COVID-19 vaccination should contact their primary care physician or schedule an appointment with the health department by clicking here. Those who schedule appointments will currently be given the two-shot Moderna vaccine at the Graham County Health Department Vaccination Center at 627 W. Main Street in Downtown Safford. The health department will announce a clinic for the one-shot Johnson and Johnson vaccine at a later date. While the Pfizer and Moderna two-shot vaccines utilize messenger RNA, the Johnson & Johnson vaccine works through a different mechanism and uses the more traditional DNA, which is introduced to the nucleus of cells with an adenovirus which is modified so it cannot replicate itself and cause disease. All three vaccines have been approved for use by the federal government and have safety records in good standing. All prompt the body to produce T-cells, which retain a memory of the protein and attack it. “We would like to thank everyone for their support as we have navigated through the COVID-19 pandemic this past year,” said Graham County Health Department Director Brian Douglas. Greenlee County Gila Health Resources in Greenlee County will hold a COVID-19 vaccine drive at the Morenci Club Hall at 314 Plaza Dr. in Morenci on Friday, March 19, from 1 – 8 p.m. At the vaccine drive, any adult resident of Greenlee County or those who work in Greenlee County can show up to receive a dose of the Moderna vaccine with no appointment or registration necessary.
• 
  2021-03-21

  San Carlos (AZ) to hold a drive-through COVID-19 vaccine clini6c

  March 22, 2021 - by News Director Contributed Article SAN CARLOS – The San Carlos Apache Healthcare Corporation is proud to present a COVID-19 vaccine drive-through clinic for SCAT members and their family and friends of the surrounding communities of Globe, Miami, Superior, Hayden, Winkleman, Kearny, Pima, Thatcher, Safford, and Morenci. Our SCAHC Vaccination team will be administering the Pfizer and Moderna vaccine at the San Carlos High School, on Saturday, March 27, from 8 a.m. – 4 p.m. No appointment is necessary. For the Pfizer vaccine, those receiving it must be 16 years of age or older (must have a parent/legal guardian consent if under 18) For the Moderna vaccine, those receiving it must be 18 years of age or older. Please remember to bring your state ID. There is no charge for the vaccine.
• 
  12/10/2020

  Moderna vaccine to be available to 75% of 'eligible population' in N.W.T in early 2021

  The Northwest Territories government expects the Moderna vaccine for COVID-19 to be available to 75 per cent of the territory's "eligible population" in "early 2021," according to a media advisory issued Thursday afternoon.
• 
  2020-11-18

  "The End of the Pandemic Is Now in Sight" - The Atlantic Monthly

  With the development of two viable COVID-19 vaccines, it appears that the end of the pandemic appears to be at hand in the near future. In an article for the Atlantic Monthly magazine, journalist Sarah Zhang explains how these viable vaccines were developed using new technologies and how the resolution of the pandemic is now more dependent on policy choices made by political leaders, namely the President of the United States. During the initial months of the COVID-19 pandemic, medical professionals, epidemiologists, and vaccinologists were in the dark about the symptoms, treatability, and curability of the disease. After months of intense hands-on experience and in-depth genomic research, the companies Pfizer and Moderna have developed viable vaccine candidates. But these vaccines are different from typical vaccines: they are mRNA vaccines. This means that they work by injecting mRNA which encodes viral proteins, rather than injecting a weakened or dead SARS-CoV-2 virus. mRNA vaccines, according to Zhang, were once thought to be potentially unviable, but the positive preliminary results of the Pfizer and Moderna mRNA vaccines may mark the beginning of a new era of vaccine research and development. In the future, Zhang says, mRNA vaccines may be developed for the Zika virus or for personalized forms of cancer. However, a major drawback of mRNA vaccines is their fragility, as they require extremely cold temperatures to be preserved. Now that these vaccines may be available for public use in the near future, it is up to the United States' political leadership to formulate policies to promote the vaccination of the populace and the mitigation of COVID-19 infections during the winter. According to Zhang, "Every infection we prevent now—through masking and social distancing—is an infection that can, eventually, be prevented forever through vaccines."
• 
  2020-11-17

  新型コロナワクチン開発　米モデルナ「94.5％効果」(2020年11月17日) - Development of new corona vaccine US Moderna "94.5% effect" (November 17, 2020)

  アメリカのバイオテクノロジー企業「モデルナ」は開発中の新型コロナウイルスのワクチンについて、「94.5％の効果が得られた」とする臨床試験の暫定的な結果を発表しました。 　モデルナは16日、ワクチン開発の最終段階となる大規模な臨床試験の結果を発表しました。新型コロナウイルスに対して「ワクチンが94.5％の確率で効果を示した」としています。アメリカではファイザー社のワクチンでも「90％以上」の有効性が確認されていて、来月中にも両社のワクチンの緊急使用が始まる可能性が出てきました。ただ、このタイプのワクチンは低温で保存・運搬する必要があるなど課題も残されています。日本政府はモデルナと2500万人分のワクチン供給を受ける契約を結んでいます。 American biotechnology company "Moderna" has announced the preliminary results of a clinical trial that "94.5% of the effect was obtained" for the new coronavirus vaccine under development. On the 16th, Moderna announced the results of a large-scale clinical trial, which is the final stage of vaccine development. "The vaccine has a 94.5% chance of being effective against the new coronavirus," he said. In the United States, Pfizer's vaccine has been confirmed to be "90% or more" effective, and it is possible the emergency use of both companies' vaccines will begin by the end of next month. However, there are still issues with this type of vaccine, such as the need to store and transport it at low temperatures. The Japanese government has a contract with Moderna to receive vaccines for 25 million people. Video translated by Youngbin Noh